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Abstract 
Alzheimer’s disease (AD) is the most common form of dementia effecting the aging population of the 
world. It is more fatal than other diseases like cancer, stroke, and heart disease. Enhancement of 
acetylcholine levels in the brain is one means of treating the disease. However, the drugs presently 
used in the management of the disease have various drawbacks. New treatments are required to get 
the potential inhibitors. In this study, extract of Capsicum annuum were evaluated to determine their 
antioxidant and Acetylcholinesterase inhibitory (AChEI) activity. The DPPH and β-carotene assays 
were used to determine antioxidant activity and Ellman’s colorimetric method to quantify 
AChEI activity. Although both ethanolic and aqueous extracts showed activity in both assays, the 
ethanolic extract of C. annuum was found to contain the highest 
AChEI activity (IC50 = 0.03 ± 0.08 mg/ml) and the antioxidant activity (β-carotene; 
IC50 = 0.14 ± 0.08 mg/ml and DPPH; IC50 = 0.23 ± 0.01 mg/ml). The results suggest that the 
tested plant may provide a substantial source of secondary metabolites, which act as 
natural antioxidants and acetylcholinesterase inhibitors, and may be beneficial in the treatment of AD. 
AChE structure shows that the enzyme possesses a deep narrow gorge which 
penetrates halfway into the enzyme, where the catalytic site resides (Kryge et al., 2000). The 
binding site of AChE consists of five subsites: a peripheral anionic site (PAS), an acyl 
binding pocket (ABP), the esteratic site (ES), an oxyanion hole (OH) and an anionic subsite 
(AS).  
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Figure 1: Representations of the molecular model of the complex formed between α-solanine and 
AChE. 3D representation of the ligand-enzyme binding interactions. α-chaconine is 
represented as a dark grey sticks and hydrogen bonds as green dashed lines. 
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